|
 |
2009/04/05/EXPERIMENTAL HEART DEVICE SHOWS PROMISE RISK ONEMEDPLACE/
The page is no longer available. You may want to read the following pages.
NM Hamburg, J Palmisano, MG Larson... - ..., 2011 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Relation of Brachial and Digital Measures of Vascular
CA Ariti, JGF Cleland, SJ Pocock, MA Pfeffer... - American Heart ..., 2011 - Elsevier Conventional composite outcomes in heart failure (HF) trials, for example, time to cardiovascular
death or first HF hospitalization, have recognized limitations. We propose an alternative
outcome, days alive and out of hospital (DAOH), which incorporates mortality and all ...
W Wu, N Smedira, T Marwick... - Journal of the ..., 2011 - Am Coll Cardio Found... Brian P. Griffin, and Milind Y. Desai Willis Wu, Nicholas Smedira, Thomas Marwick, Donald
Hammer, Bruce W. Lytle, ECHOCARDIOGRAPHIC PREDICTORS DISEASE UNDERGOING
CARDIAC SURGERY: CLINICAL AND LONG-TERM OUTCOMES OF PATIENTS WITH ...
P Higgins, J Dawson, KR Lees... - Cardiovascular ..., 2011 - Wiley Online Library Background: Xanthine oxidase inhibition (XOI) reduces oxidative stress in the vasculature. Moreover it reduces uric acid levels, a risk factor for the development of cardiovascular disease. As such, XOI holds a potentially dual mechanism for the treatment of ...
B BRADY... - Recherche, 2012 - Topics include: Cardiac Arrest as a Public Health Concern, Prehospital Cardiac Arrest, Cardiopulmonary Resuscitation, Cardioactive Medications in Cardiac Arrest, Airway Management in Cardiac Arrest, Rapid Response Teams, and Pediatric Cardiac Arrest.
|
|
|
